Maravai LifeSciences Holdings Inc
(NAS:MRVI)
$
5.92
0.3 (5.34%)
Market Cap: 839.71 Mil
Enterprise Value: 780.08 Mil
PE Ratio: 0
PB Ratio: 2.43
GF Score: 74/100 Maravai LifeSciences Holdings Inc at Stifel Healthcare Conference Transcript
Nov 14, 2023 / 03:55PM GMT
Release Date Price:
$5.17
(+4.44%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Welcome back to the 2023 Stifel Healthcare Conference. I am Dan Arias, and we are on the life sciences track here. Happy to have Maravai with us. CEO, Trey Martin; and CFO, Kevin Herde. Guys, thanks a bunch for being here.
Trey, I think maybe a good place to start would just be the CEO transition. You've been on the job for a few months. Previously, you were at Danaher, and you were running a different type of business there but adjacent, nonetheless.
Questions & Answers
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Maybe you can just talk a little bit about the strategy that you see for the company, the things that Maravai did well before and then the things you'd like to see Maravai do better, going forward?
William E. Martin
Maravai LifeSciences Holdings, Inc. - CEO
Sure. The -- my history actually in serving a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot